The effect of intravenous dexamethasone on rebound pain after wrist and hand surgery under supraclavicular brachial plexus blockade: a randomized placebo-controlled trial.
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2025;13(19):15 Can J Anaesth . 2025 Jul;72(7):1079-1089.What this means for my practice?
A single preoperative IV dose of dexamethasone (0.11 mg/kg) meaningfully reduces and delays rebound pain after single-shot SCBPB for wrist/hand surgery, lowers opioid use, and improves early patient-reported outcomes without added short-term harm. Clinically, incorporating IV dexamethasone into multimodal analgesia for these cases can smooth the transition from block resolution to systemic analgesia and curb early opioid requirements. Limitations include single-centre design, modest sample size with some baseline imbalances, exclusion of diabetes, and 24-hr follow-up only.
Study Summary
Fifty-six patients undergoing elective wrist/hand bone surgery with ultrasound-guided single-shot supraclavicular brachial plexus block (SCBPB) were randomized to receive intravenous dexamethasone 0.11 mg/kg (n=28) or intravenous 0.9% saline (n=28). The primary outcome was the difference in pain scores before versus after block resolution (NRS 0–10). Secondary outcomes included incidence of rebound pain (NRS ≥7 after block resolution), pain at rest/on mobilization at 6, 12, and 24 hr, time to worst pain, cumulative opioid use (IV morphine equivalents), patient satisfaction and sleep quality, and block/opioid-related complications through 24 hr. Overall, the results showed dexamethasone significantly lowered the primary pain-difference score and reduced rebound pain incidence, opioid consumption, and early postoperative pain, while delaying both block resolution and time to worst pain. These findings suggest a single dose of IV dexamethasone meaningfully attenuates rebound pain after SCBPB for wrist/hand surgery without increasing short-term complications.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!